These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 10719242

  • 1. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes.
    Ho E, Chen G, Bray TM.
    Free Radic Biol Med; 2000 Feb 15; 28(4):604-14. PubMed ID: 10719242
    [Abstract] [Full Text] [Related]

  • 2. Supplementation of N-acetylcysteine inhibits NFkappaB activation and protects against alloxan-induced diabetes in CD-1 mice.
    Ho E, Chen G, Bray TM.
    FASEB J; 1999 Oct 15; 13(13):1845-54. PubMed ID: 10506589
    [Abstract] [Full Text] [Related]

  • 3. Spin trapping agent phenyl N-tert-butylnitrone protects against the onset of drug-induced insulin-dependent diabetes mellitus.
    Tabatabaie T, Kotake Y, Wallis G, Jacob JM, Floyd RA.
    FEBS Lett; 1997 Apr 28; 407(2):148-52. PubMed ID: 9166889
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of the cytokine-mediated inducible nitric oxide synthase expression in rat insulinoma cells by phenyl N-tert-butylnitrone.
    Tabatabaie T, Graham KL, Vasquez AM, Floyd RA, Kotake Y.
    Nitric Oxide; 2000 Apr 28; 4(2):157-67. PubMed ID: 10835296
    [Abstract] [Full Text] [Related]

  • 5. Dietary zinc supplementation inhibits NFkappaB activation and protects against chemically induced diabetes in CD1 mice.
    Ho E, Quan N, Tsai YH, Lai W, Bray TM.
    Exp Biol Med (Maywood); 2001 Feb 28; 226(2):103-11. PubMed ID: 11446433
    [Abstract] [Full Text] [Related]

  • 6. Effect of alpha-phenyl-N-tert-butylnitrone on diabetes and lipid peroxidation in BB rats.
    Iovino G, Kubow S, Marliss EB.
    Can J Physiol Pharmacol; 1999 Mar 28; 77(3):166-74. PubMed ID: 10535689
    [Abstract] [Full Text] [Related]

  • 7. The protective effect of Amomum xanthoides extract against alloxan-induced diabetes through the suppression of NFkappaB activation.
    Park BH, Park JW.
    Exp Mol Med; 2001 Jun 30; 33(2):64-8. PubMed ID: 11460883
    [Abstract] [Full Text] [Related]

  • 8. Expression of cytokines and activation of transcription factors in lipopolysaccharide-administered rats and their inhibition by phenyl N-tert-butylnitrone (PBN).
    Sang H, Wallis GL, Stewart CA, Kotake Y.
    Arch Biochem Biophys; 1999 Mar 15; 363(2):341-8. PubMed ID: 10068457
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide formation during light-induced decomposition of phenyl N-tert-butylnitrone.
    Chamulitrat W, Jordan SJ, Mason RP, Saito K, Cutler RG.
    J Biol Chem; 1993 Jun 05; 268(16):11520-7. PubMed ID: 8099352
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of NF-kappaB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN).
    Kotake Y, Sang H, Miyajima T, Wallis GL.
    Biochim Biophys Acta; 1998 Nov 19; 1448(1):77-84. PubMed ID: 9824673
    [Abstract] [Full Text] [Related]

  • 11. In vitro and in vivo protective effect of Ganoderma lucidum polysaccharides on alloxan-induced pancreatic islets damage.
    Zhang HN, He JH, Yuan L, Lin ZB.
    Life Sci; 2003 Sep 19; 73(18):2307-19. PubMed ID: 12941433
    [Abstract] [Full Text] [Related]

  • 12. Treatment with {alpha}-phenyl-N-tert-butylnitrone, a free radical-trapping agent, abrogates inflammatory cytokine gene expression during alloimmune activation in rat cardiac allografts.
    Pieper GM, Nilakantan V, Zhou X, Khanna AK, Johnson CP, Roza AM, Adams MB, Hilton G, Felix CC.
    J Pharmacol Exp Ther; 2005 Feb 19; 312(2):774-9. PubMed ID: 15347735
    [Abstract] [Full Text] [Related]

  • 13. Protection against oxidative damage to CNS by alpha-phenyl-tert-butyl nitrone (PBN) and other spin-trapping agents: a novel series of nonlipid free radical scavengers.
    Carney JM, Floyd RA.
    J Mol Neurosci; 1991 Feb 19; 3(1):47-57. PubMed ID: 1679344
    [Abstract] [Full Text] [Related]

  • 14. The spin trap, alpha-phenyl N-tert-butylnitrone, inhibits the oxidative modification of low density lipoprotein.
    Kalyanaraman B, Joseph J, Parthasarathy S.
    FEBS Lett; 1991 Mar 11; 280(1):17-20. PubMed ID: 1849092
    [Abstract] [Full Text] [Related]

  • 15. Radical trapping and inhibition of iron-dependent CNS damage by cyclic nitrone spin traps.
    Thomas CE, Ohlweiler DF, Taylor VL, Schmidt CJ.
    J Neurochem; 1997 Mar 11; 68(3):1173-82. PubMed ID: 9048764
    [Abstract] [Full Text] [Related]

  • 16. alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice.
    Naito Y, Takagi T, Ishikawa T, Handa O, Matsumoto N, Yagi N, Matsuyama K, Yoshida N, Yoshikawa T, Kotake Y.
    Antioxid Redox Signal; 2002 Feb 11; 4(1):195-206. PubMed ID: 11970853
    [Abstract] [Full Text] [Related]

  • 17. Spin trapping agent phenyl-N-tert-butylnitrone prevents diisopropylphosphorofluoridate-induced excitotoxicity in skeletal muscle of the rat.
    Milatovic D, Zivin M, Hustedt E, Dettbarn WD.
    Neurosci Lett; 2000 Jan 07; 278(1-2):25-8. PubMed ID: 10643792
    [Abstract] [Full Text] [Related]

  • 18. The spin-trap N-tert-alpha-phenyl-butylnitrone prolongs the life span of the senescence accelerated mouse.
    Edamatsu R, Mori A, Packer L.
    Biochem Biophys Res Commun; 1995 Jun 26; 211(3):847-9. PubMed ID: 7598714
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic properties of phenyl N-tert-butylnitrone.
    Kotake Y.
    Antioxid Redox Signal; 1999 Jun 26; 1(4):481-99. PubMed ID: 11233146
    [Abstract] [Full Text] [Related]

  • 20. Spin trapping agent, phenyl N-tert-butylnitrone, reduces nitric oxide production in the rat brain during experimental meningitis.
    Endoh H, Kato N, Fujii S, Suzuki Y, Sato S, Kayama T, Kotake Y, Yoshimura T.
    Free Radic Res; 2001 Nov 26; 35(5):583-91. PubMed ID: 11767416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.